LPCAT1 participates in phospholipid metabolism by catalysing the conversion from lysophosphatidylcholine to phosphatidylcholine and has been demonstrated to be correlated with various neoplasms, including hepatoma, acute myeloid leukaemia [13], breast cancer [16], clear cell renal cell carcinoma [17], colorectal cancer [18], esophageal cancer, lung adenocarcinoma [19], oral squamous cell carcinoma [20], and prostate cancer [21]. This evidence concerns the gene LPCAT1 and clear cell renal carcinoma.